Clindamycin Palmitate Hydrochloride
Product Images NDC 10135-569

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin Palmitate Hydrochloride (NDC 10135-569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Clindamycin Palmitate Hydrochloride. (Clindamycin Palmitate Hydrochloride 01)

Chemical structure of Clindamycin Palmitate Hydrochloride shown as a detailed molecular diagram with labeled carbon, hydrogen, oxygen, chlorine, and sulfur atoms, including the hydrochloride (HCl) portion.*

FDA Label Image

Principal Display Panelndc 10135-0569-19clindamycinpalmitatehydrochloridefor Oral Solution,usp (pediatric)75 mg* / 5 mL (Clindamycin Palmitate Hydrochloride 02)

Packaging label for Clindamycin Palmitate Hydrochloride for Oral Solution, USP (Pediatric) by Marlex Pharmaceuticals, Inc. The label specifies a concentration of 75 mg per 5 mL when reconstituted, with a total volume of 100 mL when mixed. The label includes storage instructions, usage warnings, and barcode with NDC 10135-569-19. The packaging indicates the product is Rx only and provides preparation directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.